# data[].attributes.body
Gamma-Hydroxybutyric acid (GHB)
Also referred to as a “club drug” or “date rape” drug.
Commonly Referred To As:
Liquid X, Liquid ecstasy, Grievous bodily harm, Mils, G, Liquid G, Fantasy
GHB is a controlled substance, Schedule 1 Narcotic.

# data[].attributes.body
GHB or Gamma Hydroxybutyrate (C₄H₈O₃) is a central nervous system (CNS) depressant that is commonly referred to as a “club drug” or “date rape” drug.
It was first used for an experiment in 2002 for the treatment of narcolepsy, a sleep disorder that causes excessive sleepiness and recurring daytime sleep attacks. It is the sodium salt of GHB. GHB is available as an odorless, colorless drug that may be combined with alcohol and given to unsuspecting victims prior to sexual assaults. It may have a soapy or salty taste.
Source:
PharmD., L. Anderson. “GHB Drug: Effects, Hazards & Methods of Abuse.” Drugs.com, Drugs.com, 23 Apr. 2018, www.drugs.com/illicit/ghb.html.

# data[].attributes.body
GHB is abused by teens and young adults at bars, parties, clubs and “raves” (all night dance parties), and is often placed in alcoholic beverages.
Source:
PharmD., L. Anderson. “GHB Drug: Effects, Hazards & Methods of Abuse.” Drugs.com, Drugs.com, 23 Apr. 2018, www.drugs.com/illicit/ghb.html.

# data[].attributes.body
GHB has caused many teens people to need emergency medical care. Because the liquid is odorless and colorless, it's sometimes slipped unknowingly into a person's drink.

Side effects of GHB use include drowsiness, dizziness, nausea, vomiting, and vision changes. Teens who take GHB may become unconscious (pass out), stop breathing, and go into a coma. GHB use can kill, overdose is very common in teens.
Source:
“GHB.” Edited by Steven Dowshen, KidsHealth, The Nemours Foundation, 12 May 2018, kidshealth.org/en/teens/ghb.html.

# data[].attributes.body
When GHB is used frequently, repeatedly or in high doses, the chance for long term effects is much higher. The chemicals in GHB impact the human brain over time. Some GHB users report feeling highly anxious and depressed following repeated use of GHB. In addition to memory loss, decreased cognitive ability may occur which can lead to constant confusion and inability to remember basic memories.

Source:
Network, Recovery. “The Short Term and Long Term Effects of GHB.” Recovery.org, 15 Mar. 2015, www.recovery.org/forums/discussion/1087/the-short-term-and-long-term-effects-of-ghb.

# data[].attributes.body
The short term effects of GHB can occur during a high and following the immediate use of this drug. These shorter effects may last for a few hours to a few days. The most common effects include dizziness, drowsiness, confusion and “blacking out” or memory loss. A lot of users experience these symptoms while they are high. GHB leaves the system in under 48 hours, so short term effects typically leave the body quickly.
Source:
Network, Recovery. “The Short Term and Long Term Effects of GHB.” Recovery.org, 15 Mar. 2015, www.recovery.org/forums/discussion/1087/the-short-term-and-long-term-effects-of-ghb.

# data[].attributes.body
In 2002, according to the National Institute on Drug Abuse , regulators approved the manufacture and sale of GHB as a treatment for narcolepsy. People with this condition struggle with unusual episodes of sleep, and GHB seems to help these people both fall asleep faster and stay asleep through the night. When GHB was approved, regulators placed strong restrictions on the prescriptions and sales of the product. People with a prescription were placed into a registry, as were their doctors, and their refills were closely monitored. These safeguards were designed to keep GHB away from people who hoped to abuse it.
Source:
Village, Gen. “GHB Drug Abuse & Addiction in Teens.” Next Generation Village, 18 June 2017, www.nextgenerationvillage.com/drugs/prescription-drugs/ghb/.

# data[].attributes.body
GHB is a Schedule I controlled substance, meaning that it has a high potential for abuse, no currently accepted
medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. GHB
products are Schedule III substances under the Controlled Substances Act. In addition, GBL is a List I chemical. It was
placed on Schedule I of the Controlled Substances Act in March 2000. However, when sold as GHB products (such as
Xyrem), it is considered Schedule III, one of several drugs that are listed in multiple schedules.
Source:
https://www.dea.gov/druginfo/drug_data_sheets/GHB.pdf